Week 1 Flashcards
List the key biological drug targets (associated with respiratory system)
Drug Targets:
1. Enzymes
2. Receptors (on cell membranes OR intracellular i.e nuclear, cytoplasmic)
What is the mechanism of beta agonists?
Agonist - activate / trigger a response
Full agonist = full response
Partial agonist = partial response (NOT full)
Biased agonist =activates a group of receptor’s signalling cascade
Inverse agonist = produces opposite effect of natural ligand
Beta agonist (e.g. beta-adrenoreceptor) activates adenyl cyclase = increased production of cAMP
cAMP activates protein kinase A = protein phosphorylation + change in Ca2+ conc.
Causes biological response
What is the mechanism of inhaled corticosteroids?
Drug binds to receptor = hormone-receptor complex is formed
Complex enters nucleus + binds to receptor site on chromatin
Binding causes increase protein transcription
Drug: corticosteroid, hormones
What is the mechanism of muscarinic agents?
M2 and M4 receptors inhibit adenyl cyclase = decrease intracellular conc. of cAMP
M1, M3, and M5 receptors activate phospholipase C
1. causes change in Ca2+ conc. = biological response
2. activates protein kinase C = protein phosphorylation = biological response
What is the mechanism of leukotriene antagonists?
Antagonist - prevents agonist from binding to receptor
Competitive antagonist - binds to same site (as agonist)
Non-competitive - bins to different site
Reversible antagonist - short lived bonds (dissociate easily)
Irreversible antagonist - strong covalent bonds (doesn’t dissociate)
Toxicities of key drugs used to treat infection & respiratory disease
Lower drug conc. required to produce effect = high potency
Higher drug conc. required to produce effect = low potency
High doses (above therapeutic window) causes toxicity
How does a drug produce an effect?
Drug binds to a target (tight binds) forming a target-drug complex
This complex produces a response
Target usually on cell membrane, can be intracellular
If drug size, shape etc. is correct = higher affinity between target + drug